About: Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 21 September 2018

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у вересні 2018 (uk) article scientifique publié en 2018 (fr) im September 2018 veröffentlicher wissenschaftlicher Artikel (de) artículu científicu espublizáu en setiembre de 2018 (ast) scientific article published on 21 September 2018 (en)
publication date	wds:Q58706536-B0E8D3E3-72AA-4222-B2B1-17F447EA107E
publication date	2018-09-21 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q58706536-9CDB91EE-75F6-4EB4-9F93-DA9B927B8B4E
language of work or name	English
exact match	wds:Q58706536-E73EED34-3384-4332-8556-68A5C2310668
exact match	https://scigraph.springernature.com/pub.10.1186/s13046-018-0904-2
cites work	wds:Q58706536-000C7DEE-1DA9-42DD-9CB9-6C40EB755AFD wds:Q58706536-29610A6C-E911-4BA0-9094-08C78F4EA1A2 wds:Q58706536-2E1A3577-763C-4748-856F-0F733C10DB03 wds:Q58706536-4150853D-641F-4A9A-BE72-467471B6FBA8 wds:Q58706536-41DA307E-7685-4EF6-8808-56E56EED4427 wds:Q58706536-4A34BDD9-32F9-4B5C-9CAB-AFD42F1CEDB8 wds:Q58706536-6CAD6514-8604-4201-9015-4B68B900B3D2 wds:Q58706536-716C9494-AD6B-4BD7-ACE1-27A72F03615B wds:Q58706536-779B327C-D921-4036-8AB1-67B85364F460 wds:Q58706536-8CF063F2-11B7-4CEA-A394-7D0CF4A57159 wds:Q58706536-8ED2D2D4-8D03-44EE-B869-B349D473707E wds:Q58706536-9377730C-9C68-4E40-97DE-8DE41BFBA365 wds:Q58706536-93DE3229-6A77-40D8-AE7A-F43A3C318E2F wds:Q58706536-9412D425-00FB-4341-AB6D-BFFA004E7E95 wds:Q58706536-962081A2-3AF8-4A02-BAE9-C5CBB2010187 wds:Q58706536-9FCB745A-3F56-49A7-8AF1-E172A70F1EAF wds:Q58706536-A052FD7D-D2B9-461A-9257-8CBEF7FD7520 wds:Q58706536-A07DCD15-F41A-40CA-829F-03C3FB1DA522 wds:Q58706536-B29DC6F3-7FA3-4A49-B737-882F52879BF6 wds:Q58706536-B6B51F6E-4302-42E8-A314-4CC553435FD8 wds:Q58706536-C06816FA-5714-4C1E-918E-ABF79300000C wds:Q58706536-C0ED6295-84FF-44C4-BE62-AC8AEE7D4D93 wds:Q58706536-C37B996D-ADD3-47D7-B666-B3F26D511F7C wds:Q58706536-D6A4FD16-80A5-4935-A160-AEF9DE179EAC wds:Q58706536-DFFE855A-F627-40F4-886C-276C8719EDD9 wds:Q58706536-F2F98C54-9A95-48FB-A784-2CDE796B90DC wds:Q58706536-F7F12ED0-818A-4202-A10B-6DA97BE8C2B3
cites work	Effect of nitroxoline on angiogenesis and growth of human bladder cancer Erlotinib in the treatment of advanced pancreatic cancer Drug combination studies and their synergy quantification using the Chou-Talalay method Nelfinavir, A lead HIV protease inhibitor, is a broad-spectrum, anticancer agent that induces endoplasmic reticulum stress, autophagy, and apoptosis in vitro and in vivo Drug-repositioning opportunities for cancer therapy: novel molecular targets for known compounds Nelfinavir, an HIV protease inhibitor, induces apoptosis and cell cycle arrest in human cervical cancer cells via the ROS-dependent mitochondrial pathway Phase I trial of the human immunodeficiency virus protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer Recent advances in drug repositioning for the discovery of new anticancer drugs Epidermal growth factor receptor expression in human pancreatic cancer: Significance for liver metastasis Safety, pharmacokinetics, and antiretroviral activity of the potent, specific human immunodeficiency virus protease inhibitor nelfinavir: results of a phase I/II trial and extended follow-up in patients infected with human immunodeficiency virus Simultaneous targeting of the epidermal growth factor receptor and cyclooxygenase-2 pathways for pancreatic cancer therapy A phase I trial of the HIV protease inhibitor nelfinavir in adults with solid tumors Advanced pancreatic adenocarcinoma: a review of current treatment strategies and developing therapies Defining the role of the epidermal growth factor receptor in pancreatic cancer grown in vitro A flow cytometry procedure for simultaneous characterization of cell DNA content and expression of intracellular protein kinase C-zeta Nitroxoline (8-hydroxy-5-nitroquinoline) is more a potent anti-cancer agent than clioquinol (5-chloro-7-iodo-8-quinoline) ARCII: A phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancer Nelfinavir inhibits proliferation and induces DNA damage in thyroid cancer cells Current therapeutic strategies for advanced pancreatic cancer: A review for clinicians Curcumin sensitizes pancreatic cancer cells to gemcitabine by attenuating PRC2 subunit EZH2, and the lncRNA PVT1 expression. Nitroxoline induces apoptosis and slows glioma growth in vivo Repurposing of nitroxoline as a potential anticancer agent against human prostate cancer: a crucial role on AMPK/mTOR signaling pathway and the interplay with Chk2 activation Gambogic acid sensitizes gemcitabine efficacy in pancreatic cancer by reducing the expression of ribonucleotide reductase subunit-M2 (RRM2). Effects of PPARα inhibition in head and neck paraganglioma cells In vitro comparative studies of resveratrol and triacetylresveratrol on cell proliferation, apoptosis, and STAT3 and NFκB signaling in pancreatic cancer cells Sophoridine induces apoptosis and S phase arrest via ROS-dependent JNK and ERK activation in human pancreatic cancer cells Cytotoxic effect of a family of peroxisome proliferator-activated receptor antagonists in colorectal and pancreatic cancer cell lines.
author name string	wds:Q58706536-1EDE3C5D-6B2A-442C-A4E3-C18F610FFB66 wds:Q58706536-3691BD13-28F4-4756-8037-4489040A781B wds:Q58706536-447A9C09-AB56-4B8B-B387-9F3A0D04F44D wds:Q58706536-A3FF81A4-1ABF-401A-8169-CBCC52B16E76 wds:Q58706536-DA96CDFB-C8B5-42B8-80FD-431EFD376D92
author name string	Marco Marchisio Paola Lanuti Serena Veschi Rosalba Florio Alberto Massucci
rdfs:label	Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells (en) Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells (nl)
skos:prefLabel	Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells (en) Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells (nl)
name	Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells (en) Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells (nl)
author	wds:Q58706536-17778CF7-8949-4094-944C-19A2F5918EB8 wds:Q58706536-1E16C9B8-3B9B-44AD-9AD8-9208AB9311B6 wds:Q58706536-78BCFC88-4EAB-4157-8857-114379D74249 wds:Q58706536-87754C9D-E982-43C7-85C2-BFAD6EE1693E wds:Q58706536-B9BC91E8-0DA5-4F86-BF52-72D523D38656 wds:Q58706536-C38169FB-C0D9-4795-BEC2-2E96B0DD8FBE
author	Clara Natoli Nicola Tinari Pierluigi Di Sebastiano Michele De Tursi Laura De Lellis Alessandro Cama
title	wds:Q58706536-F4F3506E-64D2-4223-A2E1-15583F8C228A
title	Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells (en)
page(s)	wds:Q58706536-94DDBE38-63D7-4EFD-AC41-204F45BC920C
page(s)	236
instance of	wds:Q58706536-DFE0879D-F742-4CF2-A7E9-1EA99EBB06F8

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software